Literature DB >> 7505798

Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes.

W Cao1, B A Myers-Powell, T J Braciale.   

Abstract

There are two immunogenic sites on the type A influenza A/Japan/57 (H2N2) hemagglutinin (HA) that can be recognized by class I major histocompatibility complex (MHC), H-2Kd-restricted cytolytic T lymphocytes (CTLs). One of these sites encompasses two distinct partially overlapping epitopes, which span HA residues 204-212 and 210-219. During the analysis of the fine specificity of CTL clones directed to the HA 210-219 epitope, we found that one clone 40-2 also recognized the myeloma cell line P3x63-Ag8. P3x63-Ag8 is derived from the MOPC 21 myeloma and expresses an immunoglobulin (Ig) heavy chain variable region (VH) gene which is a member of the murine 7183 VH gene family. Recognition was specific for the endogenously processed MOPC 21 heavy chain in association with the Kd molecules, since the SP2/0 derivative of P3x63-Ag8, which does not make a functional Ig H chain, is not recognized. The VH epitope recognized by clone 40-2 could be mapped to a 10 amino acid peptide spanning MOPC 21 VH residues 49-58. Cross-reactivity for the VH gene product was also demonstrable in some heterogeneous populations of CTL generated in response to influenza virus infection. These results represent the first demonstration of cross-reactivity for an endogenously processed product of a self-Ig by the CTL directed to a foreign antigen and raise the possibility that the Ig VH expression may regulate the CD8+ T cell response to foreign antigens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7505798      PMCID: PMC2191332          DOI: 10.1084/jem.179.1.195

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  Studies on hypersensitivity. II. Delayed hypersensitivity to denatured proteins in guinea pigs.

Authors:  P G GELL; B BENACERRAF
Journal:  Immunology       Date:  1959-01       Impact factor: 7.397

2.  A nucleoprotein peptide of influenza A virus stimulates assembly of HLA-B27 class I heavy chains and beta 2-microglobulin translated in vitro.

Authors:  S Kvist; U Hamann
Journal:  Nature       Date:  1990-11-29       Impact factor: 49.962

3.  Association of class I major histocompatibility heavy and light chains induced by viral peptides.

Authors:  A Townsend; C Ohlén; J Bastin; H G Ljunggren; L Foster; K Kärre
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

Review 4.  Antigen presentation: structural themes and functional variations.

Authors:  T J Braciale; V L Braciale
Journal:  Immunol Today       Date:  1991-04

5.  Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex.

Authors:  V Ortiz-Navarrete; A Seelig; M Gernold; S Frentzel; P M Kloetzel; G J Hämmerling
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

6.  MHC class II-restricted presentation of intracellular antigen.

Authors:  S Weiss; B Bogen
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

7.  Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule.

Authors:  H Zaghouani; R Steinman; R Nonacs; H Shah; W Gerhard; C Bona
Journal:  Science       Date:  1993-01-08       Impact factor: 47.728

Review 8.  Antigen processing for presentation to T lymphocytes: function, mechanisms, and implications for the T-cell repertoire.

Authors:  J A Berzofsky; S J Brett; H Z Streicher; H Takahashi
Journal:  Immunol Rev       Date:  1988-12       Impact factor: 12.988

9.  Do B cells drive the diversification of immune responses?

Authors:  M J Mamula; C A Janeway
Journal:  Immunol Today       Date:  1993-04

10.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

View more
  5 in total

Review 1.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.

Authors:  Katja Nilges; Hanni Höhn; Henryk Pilch; Claudia Neukirch; Kirsten Freitag; P J Talbot; Markus J Maeurer
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma.

Authors:  John M Timmerman; Julie M Vose; Debra K Czerwinski; Wen-Kai Weng; Diane Ingolia; Martha Mayo; Dan W Denney; Ronald Levy
Journal:  Leuk Lymphoma       Date:  2009-01

Review 4.  DNA vaccines to attack cancer.

Authors:  Freda K Stevenson; Christian H Ottensmeier; Peter Johnson; Delin Zhu; Sarah L Buchan; Katy J McCann; Joanne S Roddick; Andrew T King; Feargal McNicholl; Natalia Savelyeva; Jason Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

5.  Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.

Authors:  Marta Mazzocco; Matteo Martini; Antonio Rosato; Elisabetta Stefani; Andrea Matucci; Silvia Dalla Santa; Francesco De Sanctis; Stefano Ugel; Sara Sandri; Giovanna Ferrarini; Tiziana Cestari; Sergio Ferrari; Paola Zanovello; Vincenzo Bronte; Silvia Sartoris
Journal:  Immunology       Date:  2015-06-15       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.